Ident. | Authors (with country if any) | Title |
---|
000019 (2020) |
H. Yu [République populaire de Chine] ; X C Wang [République populaire de Chine] ; J. Li [République populaire de Chine] ; X. Qian [République populaire de Chine] ; X F Yu [République populaire de Chine] ; Z. Sun [République populaire de Chine] ; J F Chen [République populaire de Chine] ; Q J Kao [République populaire de Chine] ; H Q Wang [République populaire de Chine] ; J C Pan [République populaire de Chine] | [Genomic analysis of a 2019-nCoV strain in the first COVID-19 patient found in Hangzhou, Zhejiang, China]. |
000058 (2020) |
Wan Beom Park [Corée du Sud] ; Nak Jung Kwon [Corée du Sud] ; Su Jin Choi [Corée du Sud] ; Chang Kyung Kang [Corée du Sud] ; Pyoeng Gyun Choe [Corée du Sud] ; Jin Yong Kim [Corée du Sud] ; Jiyoung Yun [Corée du Sud] ; Gir Won Lee [Corée du Sud] ; Moon Woo Seong [Corée du Sud] ; Nam Joong Kim [Corée du Sud] ; Jeong Sun Seo [Corée du Sud] ; Myoung Don Oh [Corée du Sud] | Virus Isolation from the First Patient with SARS-CoV-2 in Korea. |
000121 (2020) |
Qiang Ding [République populaire de Chine] ; Panpan Lu [République populaire de Chine] ; Yuhui Fan [République populaire de Chine] ; Yujia Xia [République populaire de Chine] ; Mei Liu [Allemagne] | The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China. |
000146 (2020) |
Swatantra Kumar [Inde] ; Vimal K. Maurya [Inde] ; Anil K. Prasad [Inde] ; Madan L B. Bhatt [Inde] ; Shailendra K. Saxena [Inde] | Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). |
000151 (2020) |
Junwen Luan [République populaire de Chine] ; Yue Lu [République populaire de Chine] ; Xiaolu Jin [République populaire de Chine] ; Leiliang Zhang [République populaire de Chine] | Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. |
000221 (2020) |
Tao Zhang [République populaire de Chine] ; Qunfu Wu [République populaire de Chine] ; Zhigang Zhang [République populaire de Chine] | Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. |
000234 (2020) |
Changyu Fan ; Linping Liu [République populaire de Chine] ; Wei Guo ; Anuo Yang ; Chenchen Ye ; Maitixirepu Jilili ; Meina Ren ; Peng Xu ; Hexing Long ; Yufan Wang | Prediction of Epidemic Spread of the 2019 Novel Coronavirus Driven by Spring Festival Transportation in China: A Population-Based Study |
000284 (2020) |
Wei Zhang [République populaire de Chine] ; Rong-Hui Du [République populaire de Chine] ; Bei Li [République populaire de Chine] ; Xiao-Shuang Zheng [République populaire de Chine] ; Xing-Lou Yang [République populaire de Chine] ; Ben Hu [République populaire de Chine] ; Yan-Yi Wang [République populaire de Chine] ; Geng-Fu Xiao [République populaire de Chine] ; Bing Yan [République populaire de Chine] ; Zheng-Li Shi [République populaire de Chine] ; Peng Zhou [République populaire de Chine] | Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. |
000303 (2020) |
Tarun Bhatnagar [Inde] ; Manoj V. Murhekar [Inde] ; Manish Soneja [Inde] ; Nivedita Gupta [Inde] ; Sidhartha Giri [Inde] ; Naveet Wig [Inde] ; Raman Gangakhedkar [Inde] | Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use. |
000335 (2020) |
Yuanzhe Li [République populaire de Chine] ; Feifei Guo [République populaire de Chine] ; Yang Cao [République populaire de Chine] ; Lifeng Li [République populaire de Chine] ; Yanjun Guo [République populaire de Chine] | Insight into COVID-2019 for pediatricians. |
000355 (2020) |
Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [Viêt Nam] ; Line Meddeb [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Johan Courjon [France] ; Valérie Giordanengo [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Dupont [France] ; Stéphane Honoré [France] ; Philippe Colson [France] ; Eric Chabrière [France] ; Bernard La Scola [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France] | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. |
000403 (2020) |
Kenji Mizumoto [Japon, États-Unis] ; Katsushi Kagaya [Japon] ; Alexander Zarebski [Royaume-Uni] ; Gerardo Chowell [États-Unis] | Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 |
000486 (2020) |
Ping Zhong [République populaire de Chine] ; Songxue Guo [République populaire de Chine] ; Ting Chen [République populaire de Chine] | Correlation between travellers departing from Wuhan before the Spring Festival and subsequent spread of COVID-19 to all provinces in China. |
000506 (2020) |
B. Robson [États-Unis, Royaume-Uni] | Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus |
000540 (2020) |
Wanbo Tai [États-Unis] ; Lei He [République populaire de Chine] ; Xiujuan Zhang [États-Unis] ; Jing Pu [États-Unis, République populaire de Chine] ; Denis Voronin [États-Unis] ; Shibo Jiang [États-Unis, République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis] | Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine |
000627 (2020) |
Natalia Golender [Israël] ; Velizar Bumbarov [Israël] ; Avi Eldar [Israël] ; Alessio Lorusso [Italie] ; Gabriel Kenigswald [Israël] ; Joseph Seffi Varsano [Israël] ; Dan David [Israël] ; Shani Schainin [Israël] ; Ilan Dagoni [Israël] ; Iosef Gur [Israël] ; Alon Kaplan [Israël] ; Anna Gorohov [Israël] ; Ori Koren [Israël] ; Eldad Oron [Israël] ; Yevgeny Khinich [Israël] ; Ily Sclamovich [Israël] ; Abraham Meir [Israël] ; Giovanni Savini [Italie] | Bluetongue Serotype 3 in Israel 2013–2018: Clinical Manifestations of the Disease and Molecular Characterization of Israeli Strains |
000682 (2020) |
Robyn Ralph [Canada] ; Jocelyne Lew [Canada] ; Tiansheng Zeng [République populaire de Chine] ; Magie Francis [Canada] ; Bei Xue [République populaire de Chine] ; Melissa Roux [Canada] ; Ali Toloue Ostadgavahi [Canada] ; Salvatore Rubino [Italie] ; Nicholas J. Dawe [Canada] ; Mohammed N. Al-Ahdal [Arabie saoudite] ; David J. Kelvin [République populaire de Chine] ; Christopher D. Richardson [Canada] ; Jason Kindrachuk [Canada] ; Darryl Falzarano [Canada] ; Alyson Anne Kelvin [Canada] | 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. |
000690 (2019) |
Lan Li ; Xiaoming Yu ; Haoming Zhang ; Haiwei Cheng ; Liting Hou ; Qisheng Zheng ; Jibo Hou | In vitro antiviral activity of Griffithsin against porcine epidemic diarrhea virus |
000702 (2018) |
Catherine H. Schein | Polyglutamine Repeats in Viruses |
000704 (2018) |
Marietta Nygaard [Danemark] ; Niels Smedegaard Andersen [Danemark] ; Claus Ernst Moser [Danemark] ; Gitte Olesen [Danemark] ; Ida Marie Schj Dt [Danemark] ; Carsten Heilmann [Danemark] ; Henrik Sengel V [Danemark] | Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival |
000711 (2017) |
Yoon Young Jang ; Hye Jin Park ; Hai Lee Chung | Serum YKL-40 levels may help distinguish exacerbation of post-infectious bronchiolitis obliterans from acute bronchiolitis in young children |